News
ALPMY
13.62
+2.41%
0.32
Weekly Report: what happened at ALPMY last week (0629-0703)?
Weekly Report · 16h ago
J.P. Morgan Sticks to Their Hold Rating for Astellas Pharma (ALPMF)
TipRanks · 06/29 10:35
Weekly Report: what happened at ALPMY last week (0622-0626)?
Weekly Report · 06/29 09:23
Sangamo Bankruptcy Puts Gene Therapy Platforms In Play, Eli Lilly And Astellas Circle
Benzinga · 06/23 17:46
Weekly Report: what happened at ALPMY last week (0615-0619)?
Weekly Report · 06/22 09:26
Weekly Report: what happened at ALPMY last week (0608-0612)?
Weekly Report · 06/15 09:27
AbCellera: Q3 Hot Flashes Data Drop Aside, This Stock Is A Difficult Sell
Seeking Alpha · 06/09 13:18
Weekly Report: what happened at ALPMY last week (0601-0605)?
Weekly Report · 06/08 09:25
Astellas Pharma (ALPMF) Receives a Buy from Bank of America Securities
TipRanks · 06/05 13:22
Weekly Report: what happened at ALPMY last week (0525-0529)?
Weekly Report · 06/01 09:27
Astellas Pharma (ALPMF) Gets a Buy from Macquarie
TipRanks · 05/28 10:10
Ironwood, AbbVie win U.S. label expansion for Linzess in pediatric constipation
Seeking Alpha · 05/27 15:00
Highest and lowest quant-rated healthcare stocks above $10B cap after earnings season
Seeking Alpha · 05/26 14:00
UBS Reaffirms Their Hold Rating on Astellas Pharma (ALPMF)
TipRanks · 05/25 10:26
Weekly Report: what happened at ALPMY last week (0518-0522)?
Weekly Report · 05/25 09:28
AbbVie, Merck, Astra among winners of EU drug recommendations this week
Seeking Alpha · 05/22 14:56
Weekly Report: what happened at ALPMY last week (0511-0515)?
Weekly Report · 05/18 09:28
Astellas Rated Hold as Xtandi Headwinds Offset Pipeline Potential; Price Target Reiterated at ¥2,200
TipRanks · 05/12 12:16
Weekly Report: what happened at ALPMY last week (0504-0508)?
Weekly Report · 05/11 09:26
Jazz, AstraZeneca, Astellas: Foreign Healthcare's strongest Quant picks
Seeking Alpha · 05/07 11:50
More
Webull provides a variety of real-time ALPMY stock news. You can receive the latest news about Astellas Pharma through multiple platforms. This information may help you make smarter investment decisions.
About ALPMY
Astellas Pharma Inc is a Japan-based company mainly engaged in the research, development, manufacture and sales of pharmaceutical products. The Company mainly operates Pharmaceutical Products business segment. The main products include XTANDI, BETANIS, MIRABETRIC, BETMIGA and new products ZOSPATA, EVERENZO and ENHOLTUMAB VEDOTIN, among others.